About Us
Hipertech is established in 2005 by Dr. Aytunç Yur and
Dr. Ender Inci, who are owners of HBO Group and have 7 private HBO centers in Turkey since 1997. After they have started with HBO centers, they have decided to develop hyperbaric issues. Eventually, they have established Hipertech Electronic and Industrial Cooperation Company. Currently, Hipertech involved Istanbul University as HBO Group at Istanbul University Technology Development Zone Executive Inc., also realized two Tubitak projects as succeed. Our commitment to innovation and excellence has led us to complete more than 200 hyperbaric projects worldwide, a testament to our global reach and expertise.
As Hipertech, we provide high quality customized solutions and consultancy for your projects, using more than 20 years of knowledges and experiences. Hipertech is a manufacturer of Medical Hyperbaric Oxygen Chambers and Diving Systems for Navy, Military, Governmental and Private Customers. Hipertech is able to provide solutions throughout a large area. Hipertech do implement and develop solutions with its local and international partners/suppliers for the hyperbaric and diving communities.
Our Partners
Certificates
Message from Chairman
We manufacture "hyperbaric chambers" and render top quality maintenance services. We have gained our experience in our private hyperbaric oxygen therapy centers, owned by our HBO Group company, as well as through our cooperation with university institutions and hospitals specializing in HBO therapy. In our process of creation we have gotten support from authorities in the field of medicine and technology, whose guidelines and recommendations we have been drawing on. For the purposes of subassembly and service procurement, we cooperate only with world-reputed manufacturers of medical, electronic and pressure equipment. Hipertech comply strictly with all safety standards. We have already installed several chambers all over the world. Our aim is to be a solution partner by following the progress in all technologies serving to demands of hyperbaric oxygen treatments.
AYTUNÇ YUR, MD
General Surgeon & CEO